Brind.

Adma Biologics outperformed the S&P 500 this year, operating in the biomedical sector while investors tracked earnings via Zacks Rank.

10 reports, 2 independent Updated Aug 7
Gone quiet Reached 2 outlets in its first 24 hours
Reports
10
Developments
3
Repetition
70%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Adma Biologics outperformed the S&P 500 this year, operating in the biomedical sector while investors tracked earnings via Zacks Rank.

Who's involved

What this event is mainly about
ADMA Biologics (United States)

How it developed

Newest first. Tap a step to see who reported it.
  1. ADMA Biologics initiates manufacturing with FDA approval, appoints Adam Grossman as CEO, and acquires a new operating site in Boca Raton.1 source
  2. Adma Biologics outperformed the S&P 500 this year, tracking earnings via Zacks Rank.1 source
  3. ADMA stock lagged market and sector gains on June 28, 2025.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year
  • ZacksAdma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates Adma Biologics (ADMA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This
  • ZacksAdma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note Adma Biologics (ADMA) closed at $18.59 in the latest trading session, marking a +1.81% move from the prior day. The stock exceeded
  • ZacksAdma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts Adma Biologics (ADMA) closed at $18.26 in the latest trading session, marking a +1.44% move from the prior day. The stock's performance wa
  • ZacksAdma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider In the latest close session, Adma Biologics (ADMA) was up +2.39% at $17.13. This change outpaced the S&P 500's 0.14% gain on the d
  • ZacksAdma Biologics (ADMA) Declines More Than Market: Some Information for Investors Adma Biologics (ADMA) closed the most recent trading day at $17.98, moving -3.75% from the previous trading session. Th
  • ZacksAdma Biologics (ADMA) Outperforms Broader Market: What You Need to Know Adma Biologics (ADMA) ended the recent trading session at $18.34, demonstrating a +2.98% change from the preceding day's closin
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet